NCT06616532 PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06604858 Neoadjuvant Pembrolizumab and Carboplatin Plus Paclitaxel for Stage I Triple-negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06584032 Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer Status RECRUITING Phase PHASE3
NCT06576635 LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients Status RECRUITING Phase NA
NCT06561685 A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT06561308 Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer Status RECRUITING Phase PHASE2
NCT06543576 External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunotherapy for the Treatment of Stage IVB Cervical Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06535607 Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE2
NCT06532149 ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer Status RECRUITING Phase N/A
NCT06531447 First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06524544 A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer Status RECRUITING Phase PHASE3
NCT06522828 A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients Status RECRUITING Phase PHASE2
NCT06494943 Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC Status RECRUITING Phase PHASE1/PHASE2
NCT06493019 Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer Status RECRUITING Phase PHASE2
NCT06492759 High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer Status RECRUITING Phase PHASE2
NCT06492070 Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers Status RECRUITING Phase PHASE2
NCT06490159 Predicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer Status RECRUITING Phase N/A
NCT06486441 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06476184 Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery Status RECRUITING Phase PHASE3